1990
DOI: 10.1016/0014-2999(90)94159-u
|View full text |Cite
|
Sign up to set email alerts
|

Eosinophil-eicosanoid interactions: inhibition of eosinophil chemotaxis in vivo by a LTD4-receptor antagonist

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
8
0
1

Year Published

1992
1992
2017
2017

Publication Types

Select...
7
2

Relationship

0
9

Authors

Journals

citations
Cited by 53 publications
(9 citation statements)
references
References 15 publications
0
8
0
1
Order By: Relevance
“…Bronchoprovocation studies [2, 3, 4, 5, 6, 7, 8]as well as recent clinical trials with different classes of CysLT 1 antagonists and a 5-lipoxygenase inhibitor [9, 10, 11, 12, 13, 14, 15]have provided evidence to support a role for CysLTs in inducing persistent eosinophilia in the airway and peripheral blood of asthmatic patients. Inhaled LTC 4 and/or LTD 4 caused eosinophil infiltration of the airway in the guinea pig, which was blocked by the CysLT 1 antagonist MK-571 [3]or zafirlukast [4].…”
Section: Introductionmentioning
confidence: 99%
“…Bronchoprovocation studies [2, 3, 4, 5, 6, 7, 8]as well as recent clinical trials with different classes of CysLT 1 antagonists and a 5-lipoxygenase inhibitor [9, 10, 11, 12, 13, 14, 15]have provided evidence to support a role for CysLTs in inducing persistent eosinophilia in the airway and peripheral blood of asthmatic patients. Inhaled LTC 4 and/or LTD 4 caused eosinophil infiltration of the airway in the guinea pig, which was blocked by the CysLT 1 antagonist MK-571 [3]or zafirlukast [4].…”
Section: Introductionmentioning
confidence: 99%
“…Additional but not as well-established effect is the ability of cysteinyl LTs to control eosinophil activities, including those related to tissue infiltration. Involvement of cysteinyl LTs in eosinophil influx is an in vivo phenomenon which was firstly demonstrated in guinea-pigs (Chan et al, 1990), but also observed in human (Laitinen et al, 1993) and reinforced by the anti-allergic effects of CysLT1 antagonists which, in addition to inhibiting allergic symptoms, also inhibit eosinophil recruitment during airway allergic inflammation (Peters-Golden, 2008). Even though cysteinyl LTs display negligible eosinophilotactic activity in vitro ( Figure 1 , left panel; Fregonese et al, 2002), cysteinyl LTs contribute to several mechanisms involved in mouting tissue eosinophilia, since: (i) cysteinyl receptor CysLT1 appears to play a role in eosinophilopoeisis, inasmuch as CysLT1 antagonism in vivo limits IL-5-responsive eosinophil differentiation and maturation (Saito et al, 2004); (ii) cysteinyl LTs are able to significantly up-regulate adhesion molecules, such as Mac-1 expression (Fregonese et al, 2002; Saito et al, 2004); (iii) direct administration of LTC 4 induce a rapid and significant reduction in leukocyte rolling velocity, further increasing cell adherence odds (Kanwar et al, 1995); (iv) cysteinyl LTs induce RANTES production from isolated lung cells, which in turn might cause RANTES-driven migration of eosinophils into airways (Kawano et al, 2003).…”
Section: How Do Lipid Mediators Impact Eosinophil Migration?mentioning
confidence: 99%
“…Various studies have been performed to investigate the mechanisms involved in the migration of 111 In–labelled leukocytes to areas of inflammation [15, 16, 20, 21, 24]. Teixeira et al [24]found that the accumulation of neutrophils and eosinophils at inflammatory sites in guinea–pig skin involves the leukocyte adhesion molecule, the β 2 –integrin, CD18.…”
Section: Discussionmentioning
confidence: 99%
“…Chan et al [20]demonstrated that topical application of both antigen and LTD 4 can induce late eosinophil migration in the guinea–pig conjunctiva. Intradermal injection of different known mediators of inflammation to guinea–pigs leads to a dose–dependent accumulation of 111 In–labelled eosinophils or neutrophils in the skin and local oedema formation [21, 22, 23, 24].…”
Section: Introductionmentioning
confidence: 99%